Tabuk Manufacturing Executive and Leadership Team

Ismail Shehada, the Chief Executive Officer at Tabuk Manufacturing, directs the overarching corporate strategy for the organization. Overseeing the production of generic pharmaceuticals, the Chief Executive Officer ensures that all manufacturing processes align with the rigorous regulatory standards required across the MENA region. This leadership role involves constant collaboration with the Board to prioritize investments in therapeutic areas like diabetes and cardiovascular health. By optimizing operational efficiency, Ismail Shehada drives the company toward sustainable growth and market leadership. The Chief Executive Officer monitors regional market trends to identify new opportunities for product expansion. Through the implementation of high-level governance frameworks, Shehada secures the long-term viability of the pharmaceutical portfolio. This executive focus remains fixed on delivering cost-effective medical solutions to diverse patient populations while maintaining strict quality control protocols across all manufacturing facilities.

Doaa Bugis, the Chief Executive Officer Office Manager at Tabuk Manufacturing, coordinates the daily administrative functions supporting the executive leadership team. Managing the flow of critical information between departments, the Chief Executive Officer Office Manager ensures that strategic directives from the top office reach the relevant operational units efficiently. This role involves organizing high-level meetings and facilitating communication across the various therapeutic divisions, including GI and musculoskeletal health. By streamlining internal workflows, Doaa Bugis enhances the productivity of the executive suite. The Chief Executive Officer Office Manager maintains oversight of scheduling and resource allocation to support the broader corporate mission. Through meticulous attention to detail, Bugis enables the leadership team to focus on core business objectives. This position acts as a central hub for organizational alignment, ensuring that administrative processes support the rapid delivery of pharmaceutical products to regulated markets.

Saad Stephan, the Chief Financial Officer at Tabuk Manufacturing, manages the fiscal health and capital allocation strategies for the company. Overseeing the financial reporting and budgeting processes, the Chief Financial Officer ensures that resources support the development of cost-effective pharmaceuticals for the MENA region. This leadership role involves analyzing market data to optimize pricing strategies for cardiovascular and respiratory medications. By maintaining rigorous financial controls, Saad Stephan drives the company toward improved profitability and operational stability. The Chief Financial Officer collaborates with other executives to evaluate the financial feasibility of new therapeutic product launches. Through the management of capital investments, Stephan secures the necessary funding for manufacturing infrastructure upgrades. This executive role remains essential for balancing the need for affordable medicine with the requirement for strong financial performance, ensuring that the organization meets its long-term growth targets while navigating complex regional economic landscapes.

Hatem Reda, the Chief Marketing Officer at Tabuk Manufacturing, architects the commercial strategy and brand positioning for the entire pharmaceutical portfolio. Overseeing the promotion of products within the GI, diabetes, and infection therapeutic areas, the Chief Marketing Officer ensures that the company maintains a strong presence in the competitive MENA market. This leadership role involves designing targeted campaigns that highlight the cost-effectiveness and quality of the generic drug offerings. By analyzing regional healthcare needs, Hatem Reda drives the expansion of market share across diverse territories. The Chief Marketing Officer works closely with the sales teams to ensure that product messaging resonates with healthcare providers and patients alike. Through the development of innovative commercial initiatives, Reda strengthens the market impact of the organization. This executive focus remains dedicated to increasing brand awareness and ensuring that the company effectively communicates the value of its medical solutions to all stakeholders.